Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros




Base de datos
Intervalo de año de publicación
1.
Int J Hematol ; 116(5): 807-811, 2022 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-35760941

RESUMEN

Capnocytophaga canimorsus is a Gram-negative bacillus of the commensal flora of dogs and cats that can cause infections in humans through bites, scratches or contact with oral secretions. It can be difficult to identify in clinical microbiology laboratories because of the need for specific culture media. We present the case of a patient with no relevant medical history who was admitted with septic shock, where blood smear examination was crucial for the etiologic diagnosis of Capnocytophaga canimorsus infection. The patient was also diagnosed Pelger-Huët anomaly, a condition causing a defect in neutrophil chemotaxis, which may have contributed to the severity of the infection.


Asunto(s)
Infecciones por Bacterias Gramnegativas , Anomalía de Pelger-Huët , Choque Séptico , Humanos , Capnocytophaga , Medios de Cultivo , Infecciones por Bacterias Gramnegativas/etiología , Anomalía de Pelger-Huët/diagnóstico , Choque Séptico/diagnóstico , Choque Séptico/etiología
2.
J Oncol Pharm Pract ; 27(1): 244-249, 2021 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-32517638

RESUMEN

INTRODUCTION: Nelarabine is a purine analogue approved for the treatment of patients with T-cell lymphoblastic lymphoma and T-cell acute lymphoblastic leukaemia (T-ALL) that have relapsed or are refractory to two previous chemotherapy regimens. Adverse reactions to nelarabine include neurological toxicity, the pathophysiological mechanisms of which are unknown, although the administration of intrathecal therapy at therapeutic doses given concomitantly with high-dose systemic chemotherapy that crosses the blood-brain barrier may potentiate neurotoxicity. CASE REPORT: We report a case of a 29-year-old woman with a diagnosis of relapsed T-ALL who developed severe myelopathy and polyneuropathy of toxic origin that led to paraplegia, upper-limb paresis, and dysautonomia after the first cycle of nelarabine. MANAGEMENT AND OUTCOME: Rehabilitation and pharmacological treatments were initiated early, but no evidence of a significant clinical change was obtained. DISCUSSION: Neurotoxicity is a dose-dependent side effect of nelarabine. It is therefore important to consider previously administered neurotoxic drugs before using nelarabine and to monitor patients closely so as to be able to act promptly in case of toxicity. In accordance with the data obtained and based on the Naranjo algorithm, the adverse reaction could be considered possible.


Asunto(s)
Arabinonucleósidos/efectos adversos , Leucemia-Linfoma Linfoblástico de Células T Precursoras/tratamiento farmacológico , Enfermedades de la Médula Espinal/inducido químicamente , Adulto , Arabinonucleósidos/administración & dosificación , Femenino , Humanos , Síndromes de Neurotoxicidad/etiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA